Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

$920,000, predictable hours: dermatology medicine's ‘It’ job
Health

$920,000, predictable hours: dermatology medicine's ‘It’ job

Americans’ obsession with skin care has medical students flocking to the specialty.

A surprising source of dementia relief: cannabis
Health

A surprising source of dementia relief: cannabis

While marijuana can help calm agitation, there are risks.

Australian lessons for NZ’s aged care crisis
Policy

Australian lessons for NZ’s aged care crisis

“You're not providing enough home care,” a sector leader in Australia warned.

Gregor Thompson 15 Nov 2024
J&J sues US over hospital drug-discounting programme
Health

J&J sues US over hospital drug-discounting programme

It wants to change when it gives lucrative discounts to hospitals.